CV4 BENEFIT/RISK OF IRBESARTAN/HYDROCHLOROTHIAZIDE AS FIRST-LINE TREATMENT OF SEVERE HYPERTENSION
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)64857-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)64857-7/fulltext
Title :
CV4 BENEFIT/RISK OF IRBESARTAN/HYDROCHLOROTHIAZIDE AS FIRST-LINE TREATMENT OF SEVERE HYPERTENSION
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64857-7&doi=10.1016/S1098-3015(10)64857-7
First page :
Section Title :
Open access? :
No
Section Order :
17